Well done management

Well, it seems someone may be listening to us. In the latest company presentation, OPMD is planned to be in the clinic BEFORE HBV. Although the HBV program is currently in advance of the OPMD program, this is not expected to continue to be the case. This is exactly what some of us here on HC have been advocating. Now it seems that management agrees.

The HBV program was too high a risk, given our track record. Choosing OPMD to follow the head and neck cancer program into the clinic, followed by the other programs is a much more sensible approach. Credit where credit is due, well done managment.